Researchers showed that the genetic disruption of SUV39H1, which encodes a histone-3, lysine-9 methyl-transferase, enhanced the early expansion, long-term persistence, and overall anti-tumor efficacy of human CAR T cells in leukemia and prostate cancer models.
[Cancer Discovery]